RECRUITINGOBSERVATIONAL
Myval TransAXillary Transcatheter Aortic Valve Replacement Multicenter Clinical Registry
About This Trial
Study goal is to determine the feasibility, procedural success, safety and potential benefit of the Myval transcatheter heart valve (THV) in patients undergone transaxillary (TAX) transcatheter aortic valve replacement (TAVR).
Who May Be Eligible (Plain English)
Who May Qualify:
- Patient has been treatet transaxillary (TAX) with Myval transcatheter aortic valve replacement
- BMI \<35 kg/m2
- Ability to give willing to sign a consent form
Who Should NOT Join This Trial:
- History of coronary artery bypass graft and a patent left internal mammary artery (LIMA)
- Age ≤18 years
- Patients presenting with pregnancy
- Patients without willing to sign a consent form
- Expected life expectancy \<2 years
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Patient has been treatet transaxillary (TAX) with Myval transcatheter aortic valve replacement
* BMI \<35 kg/m2
* Ability to give informed consent
Exclusion Criteria:
* History of coronary artery bypass graft and a patent left internal mammary artery (LIMA)
* Age ≤18 years
* Patients presenting with pregnancy
* Patients without informed consent
* Expected life expectancy \<2 years
Treatments Being Tested
OTHER
transaxillary (TAX) transcatheter aortic valve replacement
Study goal is to determine the feasibility, procedural success, safety and potential benefit of the Myval transcatheter heart valve (THV) in patients undergone transaxillary (TAX) transcatheter aortic valve replacement (TAVR).
Locations (1)
Universität zu Lübeck
Lübeck, Schleswig-Holstein, Germany